AdvanDx adds Candida tests to its 90-minute menu
This article was originally published in Clinica
Two more 90-minute versions of AdvanDx’s tests, this time for Candida species, have been granted US FDA 510(k) clearance. The C albicans PNA FISH (fluorescence in situ hybridisation) and C albicans/C glabrata PNA FISH tests are designed to detect the fungal species that cause the bloodstream infection Candidemia, thereby guiding appropriate antifungal therapy. Conventional methods of identifying Candida species can take five days or longer, the Woburn, Massachusetts firm says. In the meantime, patients are often treated with either fluconazole, a generic, relatively cheap antifungal drug, or echinocandin, which has broader activity but is more expensive. AdvanDx markets several other 90-minute FISH tests, including those for E coli and S aureus.